In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab

被引：32
作者：
Atanackovic, Djordje [1 ]
Yousef, Sara [1 ,2 ]
Shorter, Christa [1 ]
Tantravahi, Srinivas K. [1 ]
Steinbach, Mary [1 ]
Iglesias, Fiorella [3 ]
Sborov, Douglas [1 ]
Radhakrishnan, Sabarinath Venniyil [1 ]
Chiron, Marielle [4 ]
Miles, Rodney [5 ]
Salama, Mohamed [5 ]
Kroeger, Nicolaus [2 ]
Luetkens, Tim [1 ]
机构：
[1] Univ Utah, Huntsman Canc Inst, Hematol & Hematol Malignancies, Salt Lake City, UT 84112 USA
[2] Univ Med Ctr Hamburg Eppendorf, Dept Stem Cell Transplantat, Hamburg, Germany
[3] Univ Utah, Pediat Oncol & Hematol, Salt Lake City, UT USA
[4] Sanofi, Paris, France
[5] Univ Utah, Dept Pathol, Salt Lake City, UT USA
来源：
LEUKEMIA | 2020年 / 34卷 / 01期
关键词：
SAR650984; ANTIGENS; NY-ESO-1; CELLS;
D O I：
10.1038/s41375-019-0536-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：317 / 321
页数：5
相关论文
共 12 条
  • [1] Cancer-testis antigens are commonly expressed in multiple myeloma and induce systemic immunity following allogeneic stem cell transplantation
    Atanackovic, Djordje
    Arfsten, Julia
    Cao, Yanran
    Gnjatic, Sacha
    Schnieders, Frank
    Bartels, Katrin
    Schilling, Georgia
    Faltz, Christiane
    Wolschke, Christine
    Dierlamm, Judith
    Ritter, Gerd
    Eiermann, Thomas
    Hossfeld, Dieter Kurt
    Zander, Axel R.
    Jungbluth, Achim A.
    Old, Lloyd J.
    Bokemeyer, Carsten
    Kroeger, Nicolaus
    [J]. BLOOD, 2007, 109 (03) : 1103 - 1112
  • [2] Longitudinal Analysis and Prognostic Effect of Cancer-Testis Antigen Expression in Multiple Myeloma
    Atanackovic, Djordje
    Luetkens, Tim
    Hildebrandt, York
    Arfsten, Julia
    Bartels, Katrin
    Horn, Christiane
    Stahl, Tanja
    Cao, Yanran
    Zander, Axel R.
    Bokemeyer, Carsten
    Kroeger, Nicolaus
    [J]. CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1343 - 1352
  • [3] NY-ESO-1 specific antibody and cellular responses in melanoma patients primed with NY-ESO-1 protein in ISCOMATRIX and boosted with recombinant NY-ESO-1 fowlpox virus
    Chen, Ji-Li
    Dawoodji, Amina
    Tarlton, Andrea
    Gnjatic, Sacha
    Tajar, Abdelouahid
    Karydis, Ioannis
    Browning, Judy
    Pratap, Sarah
    Verfaille, Christian
    Venhaus, Ralph R.
    Pan, Linda
    Altman, Douglas G.
    Cebon, Jonathan S.
    Old, Lloyd L.
    Nathan, Paul
    Ottensmeier, Christian
    Middleton, Mark
    Cerundolo, Vincenzo
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (06) : E590 - E601
  • [4] SAR650984, A Novel Humanized CD38-Targeting Antibody, Demonstrates Potent Antitumor Activity in Models of Multiple Myeloma and Other CD38+ Hematologic Malignancies
    Deckert, Jutta
    Wetzel, Marie-Cecile
    Bartle, Laura M.
    Skaletskaya, Anna
    Goldmacher, Victor S.
    Vallee, Francois
    Zhou-Liu, Qing
    Ferrari, Paul
    Pouzieux, Stephanie
    Lahoute, Charlotte
    Dumontet, Charles
    Plesa, Adriana
    Chiron, Marielle
    Lejeune, Pascale
    Chittenden, Thomas
    Park, Peter U.
    Blanc, Veronique
    [J]. CLINICAL CANCER RESEARCH, 2014, 20 (17) : 4574 - 4583
  • [5] Antitumor monoclonal antibodies enhance cross-presentation of cellular antigens and the generation of myeloma-specific kill T cells dentritic cells
    Dhodapkar, KM
    Krasovsky, J
    Williamson, B
    Dhodapkar, MV
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (01) : 125 - 133
  • [6] SAR650984 directly induces multiple myeloma cell death via lysosomal-associated and apoptotic pathways, which is further enhanced by pomalidomide
    Jiang, H.
    Acharya, C.
    An, G.
    Zhong, M.
    Feng, X.
    Wang, L.
    Dasilva, N.
    Song, Z.
    Yang, G.
    Adrian, F.
    Qiu, L.
    Richardson, P.
    Munshi, N. C.
    Tai, Y-T
    Anderson, K. C.
    [J]. LEUKEMIA, 2016, 30 (02) : 399 - 408
  • [7] SURFACE EXPRESSION OF HUMAN MYELOMA CELLS - AN ANALYSIS USING A PANEL OF MONOCLONAL-ANTIBODIES
    KATAGIRI, S
    YONEZAWA, T
    TAMAKI, T
    KANAYAMA, Y
    KUYAMA, J
    OHNISHI, M
    TSUBAKIO, T
    KURATA, Y
    TARUI, S
    [J]. ACTA HAEMATOLOGICA, 1984, 72 (06) : 372 - 378
  • [8] Continued improvement in survival in multiple myeloma: changes in early mortality and outcomes in older patients
    Kumar, S. K.
    Dispenzieri, A.
    Lacy, M. Q.
    Gertz, M. A.
    Buadi, F. K.
    Pandey, S.
    Kapoor, P.
    Dingli, D.
    Hayman, S. R.
    Leung, N.
    Lust, J.
    McCurdy, A.
    Russell, S. J.
    Zeldenrust, S. R.
    Kyle, R. A.
    Rajkumar, S. V.
    [J]. LEUKEMIA, 2014, 28 (05) : 1122 - 1128
  • [9] Targeting CD38 with Daratumumab Monotherapy in Multiple Myeloma
    Lokhorst, H. M.
    Plesner, T.
    Laubach, J. P.
    Nahi, H.
    Gimsing, P.
    Hansson, M.
    Minnema, M. C.
    Lassen, U.
    Krejcik, J.
    Palumbo, A.
    van de Donk, N. W. C. J.
    Ahmadi, T.
    Khan, I.
    Uhlar, C. M.
    Wang, J.
    Sasser, A. K.
    Losic, N.
    Lisby, S.
    Basse, L.
    Brun, N.
    Richardson, P. G.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 373 (13) : 1207 - 1219
  • [10] Functional autoantibodies against SSX-2 and NY-ESO-1 in multiple myeloma patients after allogeneic stem cell transplantation
    Luetkens, Tim
    Kobold, Sebastian
    Cao, Yanran
    Ristic, Marina
    Schilling, Georgia
    Tams, Sinje
    Bartels, Britta Marlen
    Templin, Julia
    Bartels, Katrin
    Hildebrandt, York
    Yousef, Sara
    Marx, Andreas
    Haag, Friedrich
    Bokemeyer, Carsten
    Kroeger, Nicolaus
    Atanackovic, Djordje
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2014, 63 (11) : 1151 - 1162
12